Alla studier
Aktiv men inte rekryterandeOBSERVATIONELL

An Observational Study of Participants With Type 3 Von Willebrand Disease on Prophylactic Standard-of-Care Treatment

This study is for people with a severe inherited bleeding condition called Type 3 Von Willebrand Disease. If you're already receiving regular treatment (called 'prophylaxis') for this condition, this study might be for you. Researchers want to learn more about how well these treatments work in real life and how they affect your health and quality of life. They will simply observe your usual care for at least 24 weeks, without changing your treatment. This helps us understand what works best and how to improve care for others with Type 3 Von Willebrand Disease.

Överblick

Status
Aktiv men inte rekryterande
Sponsor
Hoffmann-La Roche
Inskrivningsmål
44
Starta
29 Apr 2025
Beräknad slutförande
18 Jan 2027

Vad handlar denna studie om?

This study is for individuals already diagnosed with a serious inherited bleeding disorder called Type 3 Von Willebrand Disease (VWD). This condition means your blood doesn't clot properly, leading to bleeding problems.

The main goal of this study is to gather information on how effective and safe the treatments you currently receive are. You won't be given any new medicines or asked to change your current treatment. Instead, the study will simply observe what you're already doing with your doctor and how your condition affects your daily life over about six months. This approach helps researchers understand the 'real world' impact of current treatments.

By collecting details about your health and how you feel, the study aims to improve our understanding of Type 3 VWD and how best to manage it. This information can help doctors and researchers find better ways to care for people with this condition in the future. It's a way to learn from those who live with VWD every day.

Viktiga punkter

  • Study for people with Type 3 Von Willebrand Disease already on standard treatment.
  • Observes your current care; no new drugs are given.
  • Aims to understand treatment effectiveness and quality of life.
  • Participating will last at least 24 weeks (6 months).
  • Helps improve future care for others with VWD.
  • Your medical care will not be affected if you choose not to participate or withdraw.

Vem kan vara berättigad?

To join this study, you must have a confirmed diagnosis of severe Type 3 Von Willebrand Disease. You also need to be receiving your usual, regular treatment (called 'prophylactic therapy') for your condition, typically taking it 1 to 3 times a week, and expect to continue this treatment during the study period. Your blood, liver, and kidney functions should be generally healthy.

There are also some important reasons why you might not be able to join. For example, if you have another bleeding disorder, a recent history of stomach or bowel bleeding, or a history of bleeding in the brain, you wouldn't be suitable. People who have had blood clots or are being treated for them, or those with certain other medical conditions affecting bleeding or clotting, would also not be able to participate.

Additionally, if you are pregnant, planning to become pregnant, or are of childbearing age, you would need to agree to use effective contraception throughout the study. If you're taking certain strong immune-system affecting medications (like systemic immunomodulators), you also wouldn't be able to join, though some specific medications like HIV treatments are exceptions.

Kan denna studie passa dig?

Svara på dessa snabba frågor för att se om du kan vara berättigad. Detta är endast en vägledning — forskarteamet fattar det slutgiltiga beslutet.

  1. Do I have a confirmed diagnosis of Type 3 Von Willebrand Disease?
  2. Am I currently receiving regular (prophylactic) treatment for my VWD?
  3. Am I generally healthy aside from my VWD, with good liver/kidney function?
  4. Have I had any recent stomach/bowel bleeds or bleeds in the brain?
  5. Am I pregnant or planning to become so soon?
  6. Am I generally able to attend appointments without major issues?
Svara på varje fråga för att se ditt resultat.

Vad innebär deltagande?

If you decide to take part, you will continue with your regular medical appointments and treatments as prescribed by your doctor. The study will mainly involve collecting information from your medical records and asking you about your health and quality of life through questionnaires. This will happen over at least 24 weeks (about 6 months).

You won't receive any new medications or treatments specially for the study. Instead, the researchers will observe your usual care. You'll likely have regular check-ups with the study team to record information, but these are typically planned around your existing appointments. There's no strict number of visits mentioned, as it follows your standard care.

Potentiella risker och fördelar

The main benefit of taking part is contributing valuable information that can help improve care for people with Type 3 Von Willebrand Disease in the future. Since you're receiving your usual care and no new treatments, the direct risks from the study itself are generally low. The risks would be those associated with your ongoing medical condition and its standard treatment. You are always free to leave the study at any time, for any reason, without it affecting your medical care.

Platser (25)

  • UC Davis
    Verifierat postnummer
    Sacramento, USA
  • University of Minnesota Medical Center
    Verifierat postnummer
    Minneapolis, USA
  • Washington University School of Medicine
    Verifierat postnummer
    St Louis, USA
  • UZ Leuven Gasthuisberg
    Verifierat postnummer
    Leuven, Belgien
  • Sjukhuset för sjuka barn
    Verifierat postnummer
    Toronto, Kanada
  • McGill University Health Center
    Verifierat postnummer
    Montreal, Kanada
  • IPS SURA Industriales Medellín
    Verifierat postnummer
    Medellín, Colombia
  • Hopital Claude Huriez - CHU Lille
    Verifierat postnummer
    Lille, Frankrike
  • Groupe Hospitalier Necker Enfants Malades
    Verifierat postnummer
    Paris, Frankrike
  • Universitätsklinikum Bonn
    Verifierat postnummer
    Bonn, Tyskland
  • Gerinnungszentrum Rhein-Ruhr;Gerinnungsambulanz
    Verifierat postnummer
    Duisburg, Tyskland
  • Hämophiliezentrum Med. Klinik III/Institut für Transfusionsmedizin
    Obekräftad
    Frankfurt/M., Germany

Vanliga frågor

What is Type 3 Von Willebrand Disease?

It's a serious inherited bleeding disorder where your blood doesn't clot properly, leading to increased bleeding.

Kommer min behandling att förändras om jag deltar i denna studie?

No, you will continue with your current, regular treatment as usual. The study just observes it.

Hur länge kommer jag att vara med i studien?

You will be observed for at least 24 weeks, which is about 6 months.

Do I need to visit the hospital more often for this study?

The study aims to fit around your existing appointments, so you shouldn't have many extra visits.

What kind of information will they collect?

They will collect details from your medical records and ask you questions about your health and how you feel.

Hur du får reda på mer

Prata alltid med din läkare eller specialist innan du bestämmer dig för att delta i en studie.

Diskussion

Gemenskapsdiskussion

Drivs av vårt forum på community.patient.info. Var vänlig och respektfull — detta är inte medicinsk rådgivning.